Clinical Trial Detail

NCT ID NCT02625610
Title Avelumab in First-Line Gastric Cancer (JAVELIN Gastric 100)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors EMD Serono
Indications

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma

Therapies

Oxaliplatin

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Avelumab

Capecitabine + Oxaliplatin

Age Groups: adult

No variant requirements are available.